Peace of Mind in Your APL Journey: Advanced MRD Monitoring
When you’re living with acute promyelocytic leukemia, every follow-up appointment carries that unspoken question: “Is it still gone?” The uncertainty can be overwhelming. Our PML-RARA Gene Rearrangement Quantitative MRD Monitoring Test transforms that anxiety into confidence by detecting microscopic levels of leukemia cells long before they become clinically apparent.
This isn’t just another blood test – it’s your early warning system, your reassurance, and your partner in maintaining remission. Developed specifically for APL patients who’ve undergone treatment, this test provides the precise monitoring your haematologist needs to make informed decisions about your ongoing care.
Understanding Your MRD Monitoring Test
Minimal Residual Disease (MRD) refers to the small number of cancer cells that can remain in your body after treatment, even when standard tests show no evidence of disease. Our PML-RARA test uses Real-Time PCR technology to detect and quantify these hidden cells with exceptional precision.
The test specifically looks for the PML-RARA gene rearrangement – the genetic signature unique to APL cells. By measuring how many of these rearranged genes are present, we can determine if your treatment is effectively controlling the disease or if adjustments are needed.
Who Should Consider This Essential Monitoring?
This test is specifically designed for:
- APL patients in remission who want ongoing reassurance about their status
- Individuals completing APL treatment who need regular monitoring
- Patients with changing blood counts that might indicate early relapse
- Anyone whose haematologist recommends precise molecular monitoring
- South Africans across major cities including Johannesburg, Cape Town, Durban, and Pretoria
If you’ve been diagnosed with APL and want the most accurate monitoring available, this test provides the clarity you need.
Why This Monitoring Matters for Your Health Journey
Early detection of molecular relapse allows for:
- Timely intervention before clinical symptoms appear
- More effective treatment adjustments when disease burden is low
- Reduced risk of full relapse and associated complications
- Peace of mind between regular check-ups
- Personalised treatment plans based on precise molecular data
Many patients describe the relief of knowing they’re being monitored at this sophisticated level – it transforms uncertainty into proactive management.
Understanding Your Results: Clear Guidance for Peace of Mind
Your results will clearly indicate the level of PML-RARA rearrangement detected:
- Negative/Undetectable: Excellent news – no evidence of residual disease detected at our test’s sensitivity level
- Low Positive: Minimal levels detected – your haematologist may recommend closer monitoring
- Increasing Positive: Rising levels suggest molecular relapse – immediate consultation with your specialist recommended
Every report includes detailed interpretation guidance, and our team is available to help you understand what your results mean for your specific situation.
Transparent Pricing – Exceptional Value for Your Health
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| PML-RARA MRD Monitoring | ZAR 2,050 | ZAR 250 |
Considering the potential cost of treating a full relapse, this monitoring represents exceptional value for maintaining your health and peace of mind.
Why Thousands of South Africans Trust Oracle Genomics
- Nationwide Coverage: Available across South Africa including Johannesburg, Cape Town, Durban, Pretoria, and surrounding areas
- Expert Haematology Specialists: Tests interpreted by experienced haematologists
- 99% Accuracy: State-of-the-art Real-Time PCR technology
- Rapid Turnaround: Samples processed Mon/Wed/Fri by 9am, results available Tue/Thu/Sat
- Comprehensive Support: Our team guides you through every step
Take Control of Your APL Monitoring Today
Don’t let uncertainty dictate your journey. With our advanced PML-RARA MRD monitoring, you can:
- Detect molecular relapse months before clinical symptoms
- Receive results within 24-48 hours of sample collection
- Access nationwide testing convenience
- Benefit from ZAR 250 savings on this essential monitoring
Ready to transform uncertainty into confidence? Book your test today and take the next step in proactive APL management.
Limited appointments available at special pricing. Book now to secure your ZAR 250 savings.
